Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

A--Drug Manufacturing and Formulation Program (DMFP)

Awarded
75N95024R00077Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Four indefinite delivery/indefinite quantity contracts worth up to $49,999,999 each were awarded on May 4, 2026, under the Drug Manufacturing and Formulation Program, with an ordering period spanning ten years from May 4, 2026, to May 3, 2036. Each contract was issued simultaneously with a first task order effective immediately through July 3, 2026, for a firm-fixed price of $5,000 per awardee. The solicitation, numbered 75N95024R00077, was posted on May 5, 2026, under NAICS code 325412 for pharmaceutical and medicinal product manufacturing, with no set-aside provisions applied. The contracts were awarded by the National Institutes of Health, specifically the National Institute on Drug Abuse within the Department of Health and Human Services, based in Bethesda, Maryland, and the work is to be performed in Kansas City, Missouri. Primary point of contact is Rieka N. Plugge, with secondary contact Kelly Dempsey, both reachable through NIH email addresses.

General Info

Four IDIQ contracts worth nearly $50M each for drug manufacturing, 2026–2036, initial $5K task orders, NIH NIDA awarded.

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

Contract Value

$49,999,999

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Kansas City, MO, USA

Set-Aside

NONE

Awardee

ALCHEM LABORATORIES CORPORATIONView Profile

Award Issued Date

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

8 updates
PhaseAwarded
Posted

Presolicitation

Amendment 1

Contract was updated

Amendment 2

Contract was updated

Amendment 3

Contract was updated

Amendment 4

Contract was updated

Amendment 5

Contract was updated

Type Changed

Presolicitation → Solicitation

Amendment 6

Contract was updated

Amendment 7

Contract was updated

Amendment 8

Contract was updated

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts2 people available
OfficeBethesda, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Nida
View Agency Profile
Office AddressBethesda, MD, 20892, USA
Contacts
PLUGGE RIEKA N
Kelly Dempsey

Full Description

Show more

Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00. 

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541715
New
Federal
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
Solicitation # 75N98026R00144SB
This Small Business Sources Sought notice is issued by the National Institutes of Health to identify qualified small business sources capable of providing comprehensive medicinal chemistry services for the Medicinal Chemistry Support Program for Therapeutic Development. The government seeks a turn-key operation to support preclinical drug discovery efforts, including exploratory, hit-to-lead, and lead optimization phases. Required capabilities include SAR analysis and design, synthesis, in vitro ADMET studies, computational chemistry, and compound logistics. Vendors must demonstrate the capacity to manage one to ten concurrent projects and possess the necessary technical personnel and facilities to scale operations as needed. Interested small businesses under NAICS code 541715 must submit detailed responses by September 14, 2026, addressing their in-house capabilities, professional experience, and staffing qualifications. The government is using this notice to determine if the requirement can be set aside exclusively for small businesses and to evaluate whether the services should be classified as commercial or research and development. Responses should be emailed to the designated points of contact and must include the organization's Unique Entity Identifier and small business status. This notice is for research purposes only and is not a formal solicitation for proposals.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 26 days
View Details
NAICS: 541715
New
Federal
Medicinal Chemistry Support Program for Therapeutic Development (MCSP)
Solicitation # 75N98026R00144
This Sources Sought notice is issued by the National Institutes of Health to identify qualified vendors capable of providing comprehensive medicinal chemistry services for the Medicinal Chemistry Support Program for Therapeutic Development. The government is seeking a full-service, turn-key operation to support preclinical drug discovery efforts, including exploratory, hit-to-lead, and lead optimization phases. Required capabilities include SAR analysis and design, synthesis, in vitro ADMET studies, computational chemistry, and compound logistics. Vendors must demonstrate the ability to manage between one and ten concurrent projects and provide detailed information regarding their staffing, facilities, and experience in advancing compounds toward Phase 1 clinical testing. The primary objective of this notice is to conduct market research to determine the availability of qualified sources and assess whether the requirement can be set aside for small businesses under NAICS code 541715. The government has preliminarily determined that these services are not commercial in nature, though vendors are encouraged to provide evidence if they believe the services are commercial. Interested parties must submit a detailed response by September 14, 2026, including their Unique Entity Identifier and business size status. This is not a solicitation for proposals, and the government is not responsible for any costs incurred during the response process.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

in 26 days
View Details
NAICS: 541690
Federal
Modification to Extend Services for Scientific, Operations and Administrative Resources (SOAR) Contract Program
Solicitation # OLAO-SSD-SOAR-NOI
The National Institutes of Health, through the National Institute on Drug Abuse, is executing a non-competitive extension of the Scientific, Operations, and Administrative Resources (SOAR) contract program to ensure uninterrupted support for critical biomedical research activities. The SOAR program consists of five indefinite-delivery, indefinite-quantity contracts held by Axle Informatics LLC, Gap Solutions, Inc., Kelly Services, Inc., Guidehouse Digital LLC, and 22nd Century Technologies, Inc., with a combined maximum ordering value of $3.6 billion. The current ordering period is set to expire on June 21, 2026, but this amendment extends the base ordering period by twelve months to June 21, 2027, and adds two optional six-month extensions extending through June 21, 2028. Crucially, the clause governing task order duration is being revised to permit task orders to extend up to thirty-six months beyond the conclusion of the full extended ordering period, providing necessary flexibility for a phased transition to a future competitive procurement. This extension does not increase the contract ceiling; the remaining available funds of approximately $2.17 billion will be used to fulfill new and existing task orders under the revised timeframe. The extension is justified under FAR 6.103-1 due to the uniquely specialized and highly technical nature of the services, which require deep institutional knowledge, scientifically fluent personnel such as bioinformaticists, molecular biologists, and clinical research coordinators, and seamless continuity to protect ongoing research investments, prevent disruption to NIH’s mission, and avoid costly and risky transitions. Only the incumbent contractors possess the necessary expertise and infrastructure to deliver these services without jeopardizing the integrity of active biomedical projects, benchmark studies, and translational science efforts. The effort is part of a broader HHS initiative to consolidate and refine professional service procurements and is intended as a temporary measure to allow sufficient time for a full and open competition to be planned, executed, and transitioned without operational interruption. Responses to this presolicitation are solicited through March 5, 2027, to assess potential alternatives, but award will proceed non-competitively unless compelling evidence demonstrates viable competition exists. All proposers must hold an active SAM registration, provide their Unique Entity Identifier, and certify their business size status, with submissions required via email to designated NIH points of contact.
Other Scientific and Technical Consulting Services

POSTED

6 months ago

DEADLINE

in 7 months
View Details